Therapix Biosciences Ltd. of GIVATAYIM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-19. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Amitay Weiss | Director | Bnei Brak, L3 |
| Amitay Weiss | Executive Officer | Bnei Brak, L3 |
| Eric So | Director | Givatayim, L3 |
| Eric So | Related Person | Givatayim, L3 |
| Alon Dayan | Director | Tel Aviv, L3 |
| Dr. Adi Zuloff-Shani | Executive Officer | Tel Aviv, L3 |
| Oz Adler | Executive Officer | Givatayim, L3 |
| Oz Adler | Related Person | Givatayim, L3 |
| Itschak Shrem | Director | Tel Aviv, L3 |
| Itschak Shrem | Executive Officer | Tel Aviv, L3 |
| Moshe Revach | Director | Bnei Brak, L3 |
| Lior Vider | Director | Tel Aviv, L3 |
| Amnon Ben Shay | Director | Tel Aviv, L3 |
| Liat Sidi | Director | Raanana, L3 |
| Adi Zuloff-Shani | Executive Officer | Givatayim, L3 |
| Adi Zuloff-Shani | Related Person | Givatayim, L3 |
| Amnon Ben-Shay | Director | Tel Aviv, L3 |
| Stephen Simes | Director | Givatayim, L3 |
| Stephen Simes | Related Person | Givatayim, L3 |
| Ascher Shmulewitz | Director | Givatayim, L3 |
| Ascher Shmulewitz | Executive Officer | Givatayim, L3 |
| Ascher Shmulewitz | Related Person | Givatayim, L3 |
| Amit Berger | Director | Givatayim, L3 |
| Amit Berger | Related Person | Givatayim, L3 |
| Yafit Stark | Director | Givatayim, L3 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-03-03 | D | $4.2M | $4.2M |
| 2022-06-08 | D | $10.0M | $10.0M |
| 2021-03-09 | D | $3.9M | — |
| 2019-04-09 | D | $2.2M | $2.2M |